Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study

BACKGROUND. The Hermine study observed the use of trastuzumab for metastatic breast cancer (MBC) in routine practice, including patients who received trastuzumab treatment beyond progression (TBP). PATIENTS AND METHODS. The study observed 623 patients for ≥2 years. Treatment was given according to o...

Descripción completa

Detalles Bibliográficos
Autores principales: Extra, Jean-Marc, Antoine, Eric C., Vincent-Salomon, Anne, Delozier, Thierry, Kerbrat, Pierre, Bethune-Volters, Anne, Guastalla, Jean-Paul, Spielmann, Marc, Mauriac, Louis, Misset, Jean-Louis, Serin, Daniel, Campone, Mario, Hebert, Christophe, Remblier, Céline, Bergougnoux, Loïc, Campana, Frank, Namer, Moïse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2010
Materias:
Academia–Pharma Intersect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228018/
https://www.ncbi.nlm.nih.gov/pubmed/20671105
http://dx.doi.org/10.1634/theoncologist.2009-0029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228018/
https://www.ncbi.nlm.nih.gov/pubmed/20671105
http://dx.doi.org/10.1634/theoncologist.2009-0029

Ejemplares similares